NPPA ne anti-cancer medicines ke 543 brands ke revised MRP jaari kiye, 9 November 2026 se lagu
28 October 2026 ko National Pharmaceutical Pricing Authority ne anti-cancer medicines ke 543 brands ke revised Maximum Retail Price jaari kiye, jo 9 November 2026 se lagu honge.
Summary
Department of Pharmaceuticals ke tahat National Pharmaceutical Pricing Authority (NPPA) ne 28 October 2026 ko anti-cancer medicines ke 543 brands ki revised Maximum Retail Price (MRP) list jaari ki. Nayi keemtein 9 November 2026 se lagu hongi aur manufacturers ke revised prices bhejne par list update hoti rahegi. Yeh revision excessive trade margins rokne ke liye 17 October 2026 ko announce kiye gaye 137 non-scheduled anti-cancer drugs ke Trade Margin Rationalisation ke baad hua hai. In drugs mein immunotherapy medicines, Denosumab, Pegfilgrastim aur Bevacizumab shamil hain.
Key facts
- Authority
- National Pharmaceutical Pricing Authority (NPPA)
- Under
- Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers
- Revised MRP brands
- 543 anti-cancer brands
- Lagu
- 9 November 2026
- Basis
- 17 October 2026 ko announce Trade Margin Rationalisation (TMR)
- TMR drugs
- 137 non-scheduled anti-cancer drugs
- Examples
- Immunotherapy drugs, Denosumab, Pegfilgrastim, Bevacizumab
Practice MCQs 2 questions
अक्टूबर 2026 में NPPA ने कैंसर रोधी दवाओं के कितने ब्रांडों के संशोधित MRP जारी किए?
Answer dekho
Sahi uttar: B — 543
राष्ट्रीय औषध मूल्य निर्धारण प्राधिकरण (NPPA) किस विभाग के अंतर्गत कार्य करता है?
Answer dekho
Sahi uttar: C — औषध विभाग